NVIDIA announced the India availability of the new Quadro M6000 and Quadro K1200 graphics cards for professional design and visualization applications. The company kicked off a four-city roadshow, beginning on April 24, 2015 in New Delhi, to demonstrate the value proposition of the professional graphics cards solutions to customers.
NVIDIA will also showcase its revolutionary Iray technology, a highly interactive and intuitive physically based rendering process. In combination with Quadro graphics cards, Iray provides the highest level of visual realism and interactivity in design workflows by simulating the physical behavior of light and materials, while more than doubling the rendering speed. Therefore, professionals do not need expert knowledge of computer graphics techniques to quickly achieve photorealistic results.
Through the roadshow NVIDIA will seek to increase awareness of the applications of the new Quadro M6000 and K1200 cards in a specialized setting and demonstrate how the cards deliver a superior visual computing experience to professionals.
The new Quadro M6000, NVIDIA’s most powerful graphics card ever, is built for professional design and visualization applications. It packs 12GB of GPU memory, 7.0 teraflops of peak single-precision performance, support for up to four 4K displays, and the power efficiency of NVIDIA’s Maxwell architecture in one powerful solution. Designed to deliver cutting-edge graphics performance, the Quadro M6000 is certified on more than 100 popular professional applications.
The new Quadro K1200 is the fastest graphics card specifically designed for small form factor (SFF) workstations. Packing in 512 CUDA parallel-processing cores, 4GB of GPU memory and a flexible single-slot, low-profile form factor, K1200 is the ideal solution for space and power-constrained chassis.
While Quadro M6000 represents the sheer compute power and visualization capabilities of the Quadro range, the Quadro K1200 will be a mid-range solution for professionals working on leaner workstations.
Comments
Post a Comment